What is AccuRx?
AccuRx is an innovative platform designed to streamline communication between patients and healthcare professionals, thereby enhancing patient care within the National Health Service (NHS). The software serves as a critical connective tissue, linking various stakeholders across the healthcare ecosystem to improve the efficiency and effectiveness of patient management. Its widespread adoption is evident, with 98% of GP practices and 68% of NHS trusts leveraging its services. AccuRx extends its support across primary care, secondary care, community and mental health services, and integrated care initiatives, positioning it as a vital tool for modern healthcare delivery.
How much funding has AccuRx raised?
AccuRx has raised a total of $38.1M across 1 funding round:
Series B
$38.1M
Series B (2021): $38.1M with participation from British Patient Capital, Lakestar, and Latitude VS
Key Investors in AccuRx
British Patient Capital
British Patient Capital, part of the government-owned British Business Bank, specializes in providing financial support to UK businesses, including equity finance, to foster growth and innovation.
Lakestar
Lakestar is a venture capital firm focused on partnering with visionary tech entrepreneurs across sectors like Deep Tech and Healthcare, investing from Seed to Growth stages.
Latitude VS
Undisclosed investor participating in the funding round.
What's next for AccuRx?
The substantial enterprise-level funding signifies AccuRx's transition into a scaling phase, likely aimed at expanding its technological capabilities, broadening its market reach within the UK healthcare system, and potentially exploring new service integrations. This strategic investment will empower AccuRx to further solidify its position as a leader in healthcare communication technology, driving innovation and improving patient outcomes across a wider spectrum of NHS services.
See full AccuRx company page
